Published: September 02, 2004
Serologicals Corporation to Present at Thomas Weisel Partners Healthcare Tailwinds 2004

Serologicals Corporation today
announced that it is scheduled to give an investor presentation at the
Thomas Weisel Partners Healthcare Tailwinds Conference on September 10,
2004.
Bud Ingalls, Vice President, Finance and Chief Financial Officer for
Serologicals Corporation, will be making the presentation, scheduled for
10:00 a.m. (ET) at The Four Seasons Hotel in Boston, MA. The presentation
will be web cast live (audio only) and can be accessed through the
Company's website at www.serologicals.com, or at
http://www.visualwebcaster.com/event.asp?id=24348.
Serologicals Corporation, headquartered in Atlanta, Georgia, is a global
provider of biological products and enabling technologies, which are
essential for the research, development and manufacturing of biologically
based life science products. The Company's products and technologies are
used in a wide variety of innovative applications within the areas of
oncology, hematology, immunology, cardiology and infectious diseases, as
well as in the study of molecular biology. Serologicals has more than 650
employees worldwide, and its shares are traded on the NASDAQ national stock
market under the symbol SERO.
Serologicals is a registered trademark of Serologicals Royalty Company.
Copyright © 2012, MarketWire
Copyright © 2012, NewsBlaze,
Daily News